Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Tomlinson, DR AU - Gardiner, NJ TI - Glucose neurotoxicity J2 - Nat Rev Neurosci SP - 36 PY - 2008 VL - 9 SP - 36 ER - TY - JOUR LB - 2. AU - Arbelaez, AM AU - Semenkovich, K AU - Hershey, T TI - Glycemic extremes in youth with T1DM: the structural and functional integrity of the developing brain J2 - Pediatr Diabetes SP - 541 PY - 2013 VL - 14 SP - 541 ER - TY - JOUR LB - 3. AU - Davis, EA AU - Keating, B AU - Byrne, GC AU - Russell, M AU - Jones, TW TI - Hypoglycaemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM J2 - Diabetes Care SP - 22 PY - 1997 VL - 20 SP - 22 ER - TY - JOUR LB - 4. AU - Blasetti, A AU - Chiuri, RM AU - Tocco, AM AU - Di Giulio, C AU - Mattei, PA AU - Ballone, E TI - The effect of recurrent severe hypoglycaemia on cognitive performance in children with type 1 diabetes: a meta-analysis J2 - J Child Neurol SP - 1383 PY - 2011 VL - 26 SP - 1383 ER - TY - JOUR LB - 5. AU - Barnard, K AU - Thomas, S AU - Royle, P AU - Noyes, K AU - Waugh, N TI - Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review J2 - BMC Pediatr SP - 50 PY - 2010 VL - 10 SP - 50 ER - TY - JOUR LB - 6. AU - Johnson, SR AU - Cooper, MN AU - Davis, EA AU - Jones, TW TI - Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parents J2 - Diabet Med SP - 1126 PY - 2013 VL - 30 SP - 1126 ER - TY - JOUR LB - 7. AU - The Diabetes Control and Complications Trial Research Group TI - The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus J2 - N Engl J Med SP - 977 PY - 1993 VL - 329 SP - 977 ER - TY - report LB - 8. AU - Royal College of Paediatrics and Child Health; National Paediatric Diabetes Audit J2 - Annual Report 2018–2019: Care Processes and Outcomes PY - 2020 ER - TY - JOUR LB - 9. AU - DiMeglio, LA AU - Evans-Molina, C AU - Oram, RA TI - Type 1 diabetes J2 - Lancet SP - 2449 PY - 2018 VL - 391 SP - 2449 ER - TY - JOUR LB - 10. AU - Greenbaum, CJ AU - Anderson, AM AU - Dolan, LM AU - Mayer-Davis, EJ AU - Dabelea, D AU - Imperatore, G AU - SEARCH Study Group TI - Preservation of beta-cell function in autoantibody-positive youth with diabetes J2 - Diabetes Care SP - 1839 PY - 2009 VL - 32 SP - 1839 ER - TY - JOUR LB - 11. AU - Lachin, JM AU - McGee, P AU - Palmer, JP AU - DCCT/EDIC Research Group TI - Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial J2 - Diabetes SP - 739 PY - 2014 VL - 63 SP - 739 ER - TY - JOUR LB - 12. AU - Steffes, MW AU - Sibley, S AU - Jackson, M AU - Thomas, W TI - Beta-cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial J2 - Diabetes Care SP - 832 PY - 2003 VL - 26 SP - 832 ER - TY - JOUR LB - 13. AU - Vantyghem, MC AU - Raverdy, V AU - Balavoine, AS AU - Defrance, F AU - Caiazzo, R AU - Arnalsteen, L TI - Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) is required to abrogate hyperglycaemia, whereas a minimal function is necessary to suppress severe hypoglycaemia (β-score greater than 3) J2 - J Clin Endocrinol Metab SP - E2078 PY - 2012 VL - 97 SP - E2078 ER - TY - JOUR LB - 14. AU - Bluestone, JA AU - Buckner, JH AU - Herold, KC TI - Immunotherapy: building a bridge to a cure for type 1 diabetes J2 - Science SP - 510 PY - 2021 VL - 373 SP - 510 ER - TY - JOUR LB - 15. AU - Brusko, TM AU - Russ, HA AU - Stabler, CL TI - Strategies for durable beta-cell replacement in type 1 diabetes J2 - Science SP - 516 PY - 2021 VL - 373 SP - 516 ER - TY - JOUR LB - 16. AU - Cryer, PE TI - The barrier of hypoglycaemia in diabetes J2 - Diabetes SP - 3169 PY - 2008 VL - 57 SP - 3169 ER - TY - JOUR LB - 17. AU - Shah, SC AU - Malone, JI AU - Simpson, NE TI - A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus J2 - N Engl J Med SP - 550 PY - 1989 VL - 320 SP - 550 ER - TY - JOUR LB - 18. AU - Buckingham, B AU - Beck, RW AU - Ruedy, KJ AU - Cheng, P AU - Kollman, C AU - Weinzimer, SA AU - Diabetes Research in Children Network (DirecNet) Study Group TI - Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes J2 - Diabetes Care SP - 4030 PY - 2013 VL - 36 SP - 4030 ER - TY - JOUR LB - 19. AU - Phillip, M AU - Danne, T AU - Shalitin, S AU - Buckingham, B AU - Laffel, L AU - Tamborlane, W AU - Battelino, T AU - Consensus Forum Participants TI - Use of continuous glucose monitoring in children and adolescents J2 - Pediatr Diabetes SP - 215 PY - 2012 VL - 13 SP - 215 ER - TY - JOUR LB - 20. AU - Kordonouri, O AU - Hartmann, R AU - Pankowska, E AU - Rami, B AU - Kapellen, T AU - Coutant, R TI - Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study J2 - Pediatr Diabetes SP - 515 PY - 2012 VL - 13 SP - 515 ER - TY - JOUR LB - 21. AU - Bergenstal, RM AU - Klonoff, DC AU - Garg, SK AU - Bode, BW AU - Meredith, M AU - Slover, RH AU - ASPIRE In-Home Study Group TI - Threshold-based insulin-pump interruption for reduction of hypoglycaemia J2 - N Engl J Med SP - 224 PY - 2013 VL - 369 SP - 224 ER - TY - JOUR LB - 22. AU - Ly, TT AU - Nicholas, JA AU - Retterath, A AU - Lim, EM AU - Davis, EA AU - Jones, TW TI - Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycaemia in patients with type 1 diabetes: a randomized clinical trial J2 - JAMA SP - 1240 PY - 2013 VL - 310 SP - 1240 ER - TY - JOUR LB - 23. AU - Hovorka, R TI - Closed-loop insulin delivery: from bench to clinical practice J2 - Nat Rev Endocrinol SP - 385 PY - 2011 VL - 7 SP - 385 ER - TY - JOUR LB - 24. AU - Hovorka, R AU - Canonico, V AU - Chassin, LJ AU - Haueter, U AU - Massi-Benedetti, M AU - Orsini Federici, M TI - Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes J2 - Physiol Meas SP - 905 PY - 2004 VL - 25 SP - 905 ER - TY - JOUR LB - 25. AU - Wilinska, ME AU - Chassin, LJ AU - Acerini, CL AU - Allen, JM AU - Dunger, DB AU - Hovorka, R TI - Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes J2 - J Diabetes Sci Technol SP - 132 PY - 2010 VL - 4 SP - 132 ER - TY - JOUR LB - 26. AU - Wilinska, ME AU - Budiman, ES AU - Taub, MB AU - Elleri, D AU - Allen, JM AU - Acerini, CL TI - Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycaemia and hyperglycaemia risk using simulation studies J2 - J Diabetes Sci Technol SP - 1109 PY - 2009 VL - 3 SP - 1109 ER - TY - JOUR LB - 27. AU - Hovorka, R AU - Allen, JM AU - Elleri, D AU - Chassin, LJ AU - Harris, J AU - Xing, D TI - Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial J2 - Lancet SP - 743 PY - 2010 VL - 375 SP - 743 ER - TY - JOUR LB - 28. AU - Thabit, H AU - Tauschmann, M AU - Allen, JM AU - Leelarathna, L AU - Hartnell, S AU - Wilinska, ME TI - Home use of an artificial beta cell in type 1 diabetes J2 - N Engl J Med SP - 2129 PY - 2015 VL - 373 SP - 2129 ER - TY - JOUR LB - 29. AU - Tauschmann, M AU - Allen, JM AU - Wilinska, ME AU - Thabit, H AU - Stewart, Z AU - Cheng, P TI - Day-and-night hybrid closed-loop insulin delivery in adolescents with type 1 diabetes: a free-living, randomized clinical trial J2 - Diabetes Care SP - 1168 PY - 2016 VL - 39 SP - 1168 ER - TY - JOUR LB - 30. AU - Elleri, D AU - Allen, JM AU - Kumareswaran, K AU - Leelarathna, L AU - Nodale, M AU - Caldwell, K TI - Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial J2 - Diabetes Care SP - 838 PY - 2013 VL - 36 SP - 838 ER - TY - JOUR LB - 31. AU - Nimri, R AU - Danne, T AU - Kordonouri, O AU - Atlas, E AU - Bratina, N AU - Biester, T TI - The ‘Glucositter’ overnight automated closed loop system for type 1 diabetes: a randomized crossover trial J2 - Pediatr Diabetes SP - 159 PY - 2013 VL - 14 SP - 159 ER - TY - JOUR LB - 32. AU - Hovorka, R AU - Elleri, D AU - Thabit, H AU - Allen, JM AU - Leelarathna, L AU - El-Khairi, R TI - Overnight closed loop insulin delivery in young people with type 1 diabetes: a free-living randomised clinical trial J2 - Diabetes Care SP - 1204 PY - 2014 VL - 37 SP - 1204 ER - TY - JOUR LB - 33. AU - Nimri, R AU - Muller, I AU - Atlas, E AU - Miller, S AU - Kordonouri, O AU - Bratina, N TI - Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis J2 - Pediatr Diabetes SP - 91 PY - 2014 VL - 15 SP - 91 ER - TY - JOUR LB - 34. AU - Bergenstal, RM AU - Nimri, R AU - Beck, RW AU - Criego, A AU - Laffel, L AU - Schatz, D AU - FLAIR Study Group TI - A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial J2 - Lancet SP - 208 PY - 2021 VL - 397 SP - 208 ER - TY - JOUR LB - 35. AU - Breton, MD AU - Kanapka, LG AU - Beck, RW AU - Ekhlaspour, L AU - Forlenza, GP AU - Cengiz, E AU - iDCL Trial Research Group TI - A randomized trial of closed-loop control in children with type 1 diabetes J2 - N Engl J Med SP - 836 PY - 2020 VL - 383 SP - 836 ER - TY - JOUR LB - 36. AU - Brown, SA AU - Kovatchev, BP AU - Raghinaru, D AU - Lum, JW AU - Buckingham, BA AU - Kudva, YC AU - iDCL Trial Research Group TI - Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes J2 - N Engl J Med SP - 1707 PY - 2019 VL - 381 SP - 1707 ER - TY - JOUR LB - 37. AU - Tauschmann, M AU - Thabit, H AU - Bally, L AU - Allen, JM AU - Hartnell, S AU - Wilinska, ME AU - APCam11 Consortium TI - Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial J2 - Lancet SP - 1321 PY - 2018 VL - 392 SP - 1321 ER - TY - JOUR LB - 38. AU - Dovc, K AU - Boughton, C AU - Tauschmann, M AU - Thabit, H AU - Bally, L AU - Allen, JM AU - APCam11, AP@Home, and KidsAP Consortia TI - young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery J2 - Diabetes Care SP - 1344 PY - 2019 VL - 42 SP - 1344 ER - TY - JOUR LB - 39. AU - Ruan, Y AU - Thabit, H AU - Leelarathna, L AU - Hartnell, S AU - Willinska, ME AU - Dellweg, S AU - AP@home Consortium TI - Variability of insulin requirements over 12 weeks of closed-loop insulin delivery in adults with type 1 diabetes J2 - Diabetes Care SP - 830 PY - 2016 VL - 39 SP - 830 ER - TY - JOUR LB - 40. AU - Barnard, KD AU - Wysocki, T AU - Allen, JM AU - Elleri, D AU - Thabit, H AU - Leelarathna, L TI - Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents J2 - BMJ Open Diabet Res Care SP - e000025 PY - 2014 VL - 2 SP - e000025 ER - TY - JOUR LB - 41. AU - Boughton, C AU - Allen, JM AU - Tauschmann, M AU - Hartnell, S AU - Wilinska, ME AU - Musolino, G AU - CLOuD Consortium TI - Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol J2 - BMJ Open SP - e033500 PY - 2020 VL - 10 SP - e033500 ER - TY - JOUR LB - 42. AU - Swift, PG AU - International Society for Pediatric and Adolescent Diabetes TI - International Society for Pediatric and Adolescent Diabetes ISPAD clinical practice consensus guidelines 2006–2007 Diabetes education J2 - Pediatr Diabetes SP - 103 PY - 2007 VL - 8 SP - 103 ER - TY - other LB - 43. AU - National Institute for Health and Care Excellence J2 - Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management PY - 2020 ER - TY - JOUR LB - 44. AU - Lachin, JM AU - McGee, PL AU - Greenbaum, CJ AU - Palmer, J AU - Pescovitz, MD AU - Gottlieb, P AU - Skyler, J AU - Type 1 Diabetes Trial Network TI - Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes J2 - PLOS ONE SP - e26471 PY - 2011 VL - 6 SP - e26471 ER - TY - JOUR LB - 45. AU - Benjamini, Y AU - Hochberg, Y TI - Controlling the false discovery rate: a practical and powerful approach to multiple testing J2 - J Roy Stat Soc: Ser B (Methodol) SP - 289 PY - 1995 VL - 57 SP - 289 ER - TY - JOUR LB - 46. AU - The Diabetes Control and Complications Trial Research Group TI - Effect of intensive therapy on residual β-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial J2 - Ann Intern Med SP - 517 PY - 1998 VL - 128 SP - 517 ER - TY - JOUR LB - 47. AU - Kohnert, KD AU - Freyse, EJ AU - Salzsieder, E TI - Glycaemic variability and pancreatic β-cell dysfunction J2 - Curr Diabetes Rev SP - 345 PY - 2012 VL - 8 SP - 345 ER - TY - JOUR LB - 48. AU - DiMeglio, LA AU - Acerini, CL AU - Codner, E AU - Craig, ME AU - Hofer, SE AU - Pillay, K AU - Maahs, DM TI - ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes J2 - Pediatr Diabetes SP - 105 PY - 2018 VL - 19 SP - 105 ER - TY - JOUR LB - 49. AU - Lachin, JM AU - Bebu, I AU - Nathan, DM AU - DCCT/EDIC Research Group TI - The beneficial effects of earlier versus later implementation of intensive therapy in type 1 diabetes J2 - Diabetes Care SP - 2225 PY - 2021 VL - 44 SP - 2225 ER - TY - JOUR LB - 50. AU - Mortensen, HB AU - Swift, PG AU - Holl, RW AU - Hougaard, P AU - Hansen, L AU - Bjoerndalen, H AU - Hvidoere Study Group on Childhood Diabetes TI - Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis J2 - Pediatr Diabetes SP - 218 PY - 2010 VL - 11 SP - 218 ER - TY - JOUR LB - 51. AU - Varni, JW AU - Curtis, BH AU - Abetz, LN AU - Lasch, KE AU - Piault, EC AU - Zeytoonjian, AA TI - Content validity of the PedsQL™ 32 diabetes module in newly diagnosed patients with Type 1 diabetes mellitus ages 8–45 J2 - Qual Life Res SP - 2169 PY - 2013 VL - 22 SP - 2169 ER - TY - JOUR LB - 52. AU - Goodman, R TI - The Strengths and Difficulties Questionnaire: a research note J2 - J Child Psychol Psychiatry SP - 581 PY - 1997 VL - 38 SP - 581 ER - TY - JOUR LB - 53. AU - Green, LB AU - Wysocki, T AU - Reineck, BM TI - Fear of hypoglycaemia in children and adolescents with diabetes J2 - J Pediatr Psychol SP - 633 PY - 1990 VL - 15 SP - 633 ER - TY - JOUR LB - 54. AU - Cox, DJ AU - Irvine, A AU - Gonder-Frederick, L AU - Nowacek, G AU - Butterfield, J TI - Fear of hypoglycaemia: quantification, validation, and utilization J2 - Diabetes Care SP - 617 PY - 1987 VL - 10 SP - 617 ER - TY - JOUR LB - 55. AU - Gonder-Frederick, LA AU - Schmidt, KM AU - Vajda, KA AU - Greear, ML AU - Singh, H AU - Shepard, JA AU - Cox, DJ TI - Psychometric properties of the hypoglycaemia fear survey-ii for adults with type 1 diabetes J2 - Diabetes Care SP - 801 PY - 2011 VL - 34 SP - 801 ER - TY - BOOK LB - 56. AU - Corbin, J AU - Strauss, A J2 - Basics of Qualitative Research. Techniques and Procedures for Developing Grounded Theory PY - 2014 ER - TY - JOUR LB - 57. AU - Rankin, D AU - Kimbell, B AU - Hovorka, R AU - Lawton, J TI - Adolescents’ and their parents’ experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study J2 - Chronic Illn SP - 742 PY - 2021 VL - 18 SP - 742 ER - TY - JOUR LB - 58. AU - Davidson, M AU - Penney, ED AU - Muller, B AU - Grey, M TI - Stressors and self-care challenges faced by adolescents living with type 1 diabetes J2 - Appl Nurs Res SP - 72 PY - 2004 VL - 17 SP - 72 ER - TY - JOUR LB - 59. AU - Schilling, LS AU - Knafl, KA AU - Grey, M TI - Changing patterns of self-management in youth with type I diabetes J2 - J Pediatr Nurs SP - 412 PY - 2006 VL - 21 SP - 412 ER - TY - JOUR LB - 60. AU - Spencer, JE AU - Cooper, HC AU - Milton, B TI - The lived experiences of young people (13–16 years) with Type 1 diabetes mellitus and their parents: a qualitative phenomenological study J2 - Diabet Med SP - e17 PY - 2013 VL - 30 SP - e17 ER - TY - JOUR LB - 61. AU - Walker, A AU - Schatz, D AU - Johnson, C AU - Silverstein, J AU - Lyles, S AU - Rohrs, H TI - Type 1 diabetes through two lenses: comparing adolescent and parental perspectives with photovoice J2 - Int J Pediatr Endocrinol SP - 2 PY - 2016 VL - 2016 SP - 2 ER - TY - JOUR LB - 62. AU - Castensøe-Seidenfaden, P AU - Teilmann, G AU - Kensing, F AU - Hommel, E AU - Olsen, BS AU - Husted, GR TI - Isolated thoughts and feelings and unsolved concerns: adolescents’ and parents’ perspectives on living with type 1 diabetes: a qualitative study using visual storytelling J2 - J Clin Nurs SP - 3018 PY - 2017 VL - 26 SP - 3018 ER - TY - JOUR LB - 63. AU - Chilton, R AU - Pires-Yfantouda, R TI - Understanding adolescent type 1 diabetes self-management as an adaptive process: a grounded theory approach J2 - Psychol Health SP - 1486 PY - 2015 VL - 30 SP - 1486 ER - TY - JOUR LB - 64. AU - Ersig, AL AU - Tsalikian, E AU - Coffey, J AU - Williams, JK TI - Stressors in teens with type 1 diabetes and their parents: immediate and long-term implications for transition to self-management J2 - J Pediatr Nurs SP - 390 PY - 2016 VL - 31 SP - 390 ER - TY - JOUR LB - 65. AU - Rising Holmström, M AU - Häggström, M AU - Audulv, A AU - Junehag, L AU - Coyne, I AU - Söderberg, S TI - To integrate and manage diabetes in school: Youth’s experiences of living with Type 1 diabetes in relation to school – a qualitative study J2 - International Diabetes Nursing SP - 46 PY - 2017 VL - 14 SP - 46 ER - TY - JOUR LB - 66. AU - King, KM AU - King, PJ AU - Nayar, R AU - Wilkes, S TI - Perceptions of adolescent patients of the ‘lived experience’ of type 1 diabetes J2 - Diabetes Spectr SP - 23 PY - 2017 VL - 30 SP - 23 ER - TY - JOUR LB - 67. AU - Commissariat, PV AU - Kenowitz, JR AU - Trast, J AU - Heptulla, RA AU - Gonzalez, JS TI - developing a personal and social identity with type 1 diabetes during adolescence: a hypothesis generative study J2 - Qual Health Res SP - 672 PY - 2016 VL - 26 SP - 672 ER - TY - JOUR LB - 68. AU - Dickinson, JK AU - O’Reilly, MM TI - The lived experience of adolescent females with type 1 diabetes J2 - Diabetes Educ SP - 99 PY - 2004 VL - 30 SP - 99 ER - TY - JOUR LB - 69. AU - Kyngäs, H AU - Barlow, JD TI - an adolescent’s perspective J2 - J Adv Nurs SP - 941 PY - 1995 VL - 22 SP - 941 ER - TY - JOUR LB - 70. AU - Barnard, KD AU - Wysocki, T AU - Ully, V AU - Mader, JK AU - Pieber, TR AU - Thabit, H TI - Closing the loop in adults, children and adolescents with suboptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy J2 - J Diabetes Sci Technol SP - 1080 PY - 2017 VL - 11 SP - 1080 ER - TY - JOUR LB - 71. AU - Kimbell, B AU - Rankin, D AU - Ashcroft, NL AU - Varghese, L AU - Allen, JM AU - Boughton, CK TI - What training, support, and resourcing do health professionals need to support people using a closed-loop system? A qualitative interview study with health professionals involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) trial J2 - Diabetes Technol Ther SP - 468 PY - 2020 VL - 22 SP - 468 ER - TY - JOUR LB - 72. AU - Lawton, J AU - Kimbell, B AU - Rankin, D AU - Ashcroft, NL AU - Varghese, L AU - Allen, JM AU - CLOuD Consortium TI - Health professionals’ views about who would benefit from using a closed-loop system: a qualitative study J2 - Diabet Med: J Br Diabet Assoc SP - 1030 PY - 2020 VL - 37 SP - 1030 ER -